CVE-2021-43935
ICSMA-21-343-01 Hillrom Welch Allyn Cardio Products
Vexday Risk Score
21Low
SSVC decision (CISA)
Track
No exploitation signal → monitor
CVSS 8.1EPSS 1.1%KEV nãoPoC —Nuclei —Metasploit —Patch —
Lifecycle
15 Dec 2021Published on NVD
Recommendation: Monitor — no exploitation signal at the moment.
The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges.
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H
Affected products
Hillrom · Welch Allyn Connex CardioHillrom · Welch Allyn Diagnostic Cardiology SuiteHillrom · Welch Allyn H-Scribe Holter Analysis SystemHillrom · Welch Allyn Q-Stress Cardiac Stress Testing SystemHillrom · Welch Allyn R-Scribe Resting ECG SystemHillrom · Welch Allyn Vision ExpressHillrom · Welch Allyn X-Scribe Cardiac Stress Testing SystemWant to know if your infrastructure is exposed to this?
Talk to TrueHacking →